How can I help your business

• Draft and prosecute patent applications across key jurisdictions, including Europe, the US, China, Japan, Australia, and Canada.
• Conduct freedom‑to‑operate analyses, IP due diligence, and provide IP training to support commercialisation strategies.
• Assist clients in agritech and pharmaceutical innovation, ensuring patent portfolios align with scientific, technical, and commercial requirements.

Overview & Expertise

Georgia is an Associate at Marks & Clerk’s in the Life Sciences team, based in Cambridge. She supports clients in the agritech and pharmaceutical sectors with the drafting and prosecution of patent applications across major jurisdictions, with a particular focus on European filings. She is known for her analytical approach and growing expertise in complex biotechnological innovations.

Her work includes preparing and prosecuting international and national patent applications, performing freedom‑to‑operate assessments, and conducting IP due diligence. Georgia supports a diverse client base — from start‑ups and SMEs to multinational companies and research institutions — helping them shape patent portfolios that support long‑term R&D and commercial objectives.

Georgia has hands‑on experience with technologies including chimeric plant proteins, genetically modified crops, advanced plant transformation systems such as plant‑based Omega‑3 production, therapeutic proteins, stem cells, pharmaceutical compositions, and nucleic acid sequencing.

Georgia holds a First Class Integrated Master’s degree in Biosciences from Durham University, where she specialised in biomedical sciences and gained extensive research experience.

Client Work & Case Experience

• In 2025, Georgia completed a secondment with a global pharmaceutical company headquartered in Cambridge. During this time, she contributed to the onboarding and management of a complex international patent portfolio covering multiple on‑market products, including anti‑fungal medicines, ADD/ADHD treatments, a first‑in‑class chemotherapeutic, and opioid antagonists.
• Georgia regularly provides IP and commercialisation training to clients, offering clear, practical guidance tailored to the needs of spin‑outs, early‑stage companies, and research‑driven teams.